Alexion could be acquired for $130-$140 per share, says Oppenheimer

theflyonthewall.com

After Bloomberg reported that Roche (RHHBY) is seeking financing for a possible acquisition of Alexion (ALXN), Oppenheimer views Alexion as an attractive target and thinks the company could be acquired for $130-$140 per share. The firm reiterates an Outperform rating on the stock.

View Comments (0)